Browse > Article

A Case of Pancreatic Cancer and Opioid Withdrawal after Endoscopic Ultrasound-guided Celiac Plexus Neurolysis  

Seol, Soo-Hwan (Department of Gastroenterology, Fatima Hospital)
Kim, Hyun-Soo (Department of Gastroenterology, Fatima Hospital)
Hwang, Byung-Sik (Department of Gastroenterology, Fatima Hospital)
Oh, Dae-Myung (Department of Gastroenterology, Fatima Hospital)
Baek, In-Yub (Department of Gastroenterology, Fatima Hospital)
Park, Min-Kyu (Department of Gastroenterology, Fatima Hospital)
Ryu, Hyon-Uk (Department of Gastroenterology, Fatima Hospital)
Kwon, Jong-Kyu (Department of Gastroenterology, Fatima Hospital)
Publication Information
Clinical Endoscopy / v.42, no.5, 2011 , pp. 323-326 More about this Journal
Abstract
Pancreatic cancer is usually unresectable upon diagnosis, and treatment aims to optimize the quality of the patient's life by managing symptoms, and, particularly, by providing adequate pain control. When the pain is refractory to opioids, interventions such as celiac plexus neurolysis (CPN) can be considered. Endoscopic ultrasound (EUS)-guided CPN has been introduced for pancreatic cancer. Reported herein is a case of a 75 year-old man with pancreatic cancer who was treated with opioids due to severe abdominal pain. EUS-guided CPN was performed for pain control, and the opioid administration was discontinued as the pain improved dramatically. However, the patient experienced opioid withdrawal symptoms, including anxiety, insomnia, nausea, and vomiting. Thus, although EUS-guided CPN successfully reduced pain in a patient undergoing such treatment and to whom opioid was administered, opioid administration should not be abruptly discontinued. Rather, the opioid dose should be reduced gradually to avoid drug withdrawal.
Keywords
Endoscopic-ultrasound-guided celiac plexus neurolysis; Pancreatic cancer; Opioid withdrawal;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ventafridda GV, Caraceni AT, Sbanotto AM, Barletta L, De Conno F. Pain treatment in cancer of the pancreas. Eur J Surg Oncol 1990;16:1-6.
2 Dumas EO, Pollack GM. Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective. AAPS J 2008;10:537-551.   DOI
3 Collett BJ. Opioid tolerance: the clinical perspective. Br J Anaesth 1998;81:58-68.   DOI   ScienceOn
4 Chak A. What is the evidence for EUS-guided celiac plexus block/neurolysis? Gastrointest Endosc 2009;69(suppl 2):172S-173S.   DOI
5 Wiersema MJ, Wiersema LM. Endosonography-guided celiac plexus neurolysis. Gastrointest Endosc 1996;44:656-662.   DOI   ScienceOn
6 el-Kamar FG, Grossbard ML, Kozuch PS. Metastatic pancreatic cancer: emerging strategies in chemotherapy and palliative care. Oncologist 2003;8:18-34.
7 Molinari M, Helton WS, Espat NJ. Palliative strategies for locally advanced unresectable and metastatic pancreatic cancer. Surg Clin North Am 2001;81:651-666.   DOI   ScienceOn
8 Brescia FJ. Palliative care in pancreatic cancer. Cancer Control 2004;11:39-45.   DOI
9 Carr DB, Goudas LC, Balk EM, Bloch R, Ioannidis JP, Lau J. Evidence report on the treatment of pain in cancer patients. J Natl Cancer Inst Monogr 2004;32:23-31.
10 Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 1995;63:65-76.   DOI   ScienceOn
11 Levy MJ, Wiersema MJ. EUS-guided celiac plexus neurolysis and celiac plexus block. Gastrointest Endosc 2003;57:923-930.   DOI   ScienceOn
12 Patt R. Outcomes, efficacy, complications and sequelae of visceral pain management. In: Raj PR, ed. Practical management of pain. 3rd ed. St. Louis: Mosby, 2000:904.
13 Gunaratnam NT, Sarma AV, Norton ID, Wiersema MJ. A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest Endosc 2001;54:316-324.   DOI   ScienceOn
14 Davies DD. Incidence of major complications of neurolytic coeliac plexus block. J R Soc Med 1993;86:264-266.
15 O'Toole TM, Schmulewitz N. Complication rates of EUS-guided celiac plexus blockade and neurolysis: results of a large case series. Endoscopy 2009;41:593-597.   DOI   ScienceOn
16 Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007;129:235-255.   DOI   ScienceOn
17 Gowing LR, Farrell M, Ali RL, White JM. Alpha2-adrenergic agonists in opioid withdrawal. Addiction 2002;97:49-58.   DOI   ScienceOn
18 Gowing LR, Ali RL. The place of detoxification in treatment of opioid dependence. Curr Opin Psychiatry 2006;19:266-270.   DOI   ScienceOn